Cargando…

Coinfection of HIV and hepatitis C increases complication rates after total joint arthroplasty

Introduction: As advances in efficacy of human immunodeficiency virus (HIV) and hepatitis-C virus (HCV) anti-viral medications increase, patients are able to maintain higher quality of lives than ever before. While these patients live longer lives, the unique patient population of those co-infected...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Christopher, Cornell, Ella, Dicken, Quinten, Freccero, David, Mattingly, David, Smith, Eric L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDP Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507831/
https://www.ncbi.nlm.nih.gov/pubmed/32960168
http://dx.doi.org/10.1051/sicotj/2020035
_version_ 1783585308604891136
author Fang, Christopher
Cornell, Ella
Dicken, Quinten
Freccero, David
Mattingly, David
Smith, Eric L.
author_facet Fang, Christopher
Cornell, Ella
Dicken, Quinten
Freccero, David
Mattingly, David
Smith, Eric L.
author_sort Fang, Christopher
collection PubMed
description Introduction: As advances in efficacy of human immunodeficiency virus (HIV) and hepatitis-C virus (HCV) anti-viral medications increase, patients are able to maintain higher quality of lives than ever before. While these patients live longer lives, the unique patient population of those co-infected with both HIV and HCV increases. As these older patients seek orthopaedic care, it is important to understand their unique outcome profile. The purpose of this study was to evaluate the complication rate after total joint arthroplasty (TJA) in patients with HIV and HCV coinfection compared with patients with HIV or HCV only. Methods: A retrospective review of patients undergoing primary total joint arthroplasty (TJA) at our urban, academic hospital between April 2016 and April 2019 was conducted. Patients were stratified into three groups according to viral status: HIV only, HCV only, or HIV and HCV coinfection. Baseline demographics, intravenous drug (IV) use, surgery type, CD4+ count, follow-up and complications were analysed. Results: Of the 133 patients included in the study, 28 had HIV, 88 had HCV and 17 were coinfected with both HIV and HCV. Coinfected patients were more likely to have a lower BMI (p < 0.039) and a history of IV drug use (p < 0.018) compared to patients with either HIV or HCV only. Coinfected patients had a higher complication rate (41%) than both HIV only (7%; p < 0.001) and HCV only (12.5%; p < 0.001) patients. Discussion: Patients coinfected with HIV and HCV undergoing TJA have a higher complication rate than patients with either infection alone. As this unique population of coinfected patients continues to expand, increasingly they will be under the care of arthroplasty surgeons. Improved awareness and understanding of the baseline demographic differences between these patients is paramount. Recognition of the increased complication rates grants the opportunity to improve their orthopaedic care through preoperative and multidisciplinary management.
format Online
Article
Text
id pubmed-7507831
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher EDP Sciences
record_format MEDLINE/PubMed
spelling pubmed-75078312020-10-02 Coinfection of HIV and hepatitis C increases complication rates after total joint arthroplasty Fang, Christopher Cornell, Ella Dicken, Quinten Freccero, David Mattingly, David Smith, Eric L. SICOT J Original Article Introduction: As advances in efficacy of human immunodeficiency virus (HIV) and hepatitis-C virus (HCV) anti-viral medications increase, patients are able to maintain higher quality of lives than ever before. While these patients live longer lives, the unique patient population of those co-infected with both HIV and HCV increases. As these older patients seek orthopaedic care, it is important to understand their unique outcome profile. The purpose of this study was to evaluate the complication rate after total joint arthroplasty (TJA) in patients with HIV and HCV coinfection compared with patients with HIV or HCV only. Methods: A retrospective review of patients undergoing primary total joint arthroplasty (TJA) at our urban, academic hospital between April 2016 and April 2019 was conducted. Patients were stratified into three groups according to viral status: HIV only, HCV only, or HIV and HCV coinfection. Baseline demographics, intravenous drug (IV) use, surgery type, CD4+ count, follow-up and complications were analysed. Results: Of the 133 patients included in the study, 28 had HIV, 88 had HCV and 17 were coinfected with both HIV and HCV. Coinfected patients were more likely to have a lower BMI (p < 0.039) and a history of IV drug use (p < 0.018) compared to patients with either HIV or HCV only. Coinfected patients had a higher complication rate (41%) than both HIV only (7%; p < 0.001) and HCV only (12.5%; p < 0.001) patients. Discussion: Patients coinfected with HIV and HCV undergoing TJA have a higher complication rate than patients with either infection alone. As this unique population of coinfected patients continues to expand, increasingly they will be under the care of arthroplasty surgeons. Improved awareness and understanding of the baseline demographic differences between these patients is paramount. Recognition of the increased complication rates grants the opportunity to improve their orthopaedic care through preoperative and multidisciplinary management. EDP Sciences 2020-09-19 /pmc/articles/PMC7507831/ /pubmed/32960168 http://dx.doi.org/10.1051/sicotj/2020035 Text en © The Authors, published by EDP Sciences, 2020 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Fang, Christopher
Cornell, Ella
Dicken, Quinten
Freccero, David
Mattingly, David
Smith, Eric L.
Coinfection of HIV and hepatitis C increases complication rates after total joint arthroplasty
title Coinfection of HIV and hepatitis C increases complication rates after total joint arthroplasty
title_full Coinfection of HIV and hepatitis C increases complication rates after total joint arthroplasty
title_fullStr Coinfection of HIV and hepatitis C increases complication rates after total joint arthroplasty
title_full_unstemmed Coinfection of HIV and hepatitis C increases complication rates after total joint arthroplasty
title_short Coinfection of HIV and hepatitis C increases complication rates after total joint arthroplasty
title_sort coinfection of hiv and hepatitis c increases complication rates after total joint arthroplasty
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507831/
https://www.ncbi.nlm.nih.gov/pubmed/32960168
http://dx.doi.org/10.1051/sicotj/2020035
work_keys_str_mv AT fangchristopher coinfectionofhivandhepatitiscincreasescomplicationratesaftertotaljointarthroplasty
AT cornellella coinfectionofhivandhepatitiscincreasescomplicationratesaftertotaljointarthroplasty
AT dickenquinten coinfectionofhivandhepatitiscincreasescomplicationratesaftertotaljointarthroplasty
AT freccerodavid coinfectionofhivandhepatitiscincreasescomplicationratesaftertotaljointarthroplasty
AT mattinglydavid coinfectionofhivandhepatitiscincreasescomplicationratesaftertotaljointarthroplasty
AT smithericl coinfectionofhivandhepatitiscincreasescomplicationratesaftertotaljointarthroplasty